
Fragments were isolated from subclones containing the insulin receptor cDNA described. Probe 1 as obtained from an SP64 subclone containing the 1011bp EcoRI fragment from the 5{prime} region of the U11rich cDNA. Probe 1 was a 677bp XhoI/EcoRI fragment from the {alpha} subunit region of the IR cDNA corresponding to nucleotides 334 to 1011, the putative ligand binding domain. Probe 2 was obtained from an SP64 subclone containing the 4190bp EcoRI fragment from the 3{prime} end of the U11rich cDNA. Probe 2 was a 1599 bp PstI fragment from the {beta} subunit region of the insulin receptor cDNA corresponding to nucleotides 2746 to 4345, encoding the tyrosine kinase domain. Segregation in at least one family was observed for the PstI, KpnI, and RsaI ({beta}) polymorphisms.
Polymorphism, Genetic, Humans, DNA Restriction Enzymes, DNA Probes, Deoxyribonucleases, Type II Site-Specific, Polymorphism, Restriction Fragment Length, Receptor, Insulin
Polymorphism, Genetic, Humans, DNA Restriction Enzymes, DNA Probes, Deoxyribonucleases, Type II Site-Specific, Polymorphism, Restriction Fragment Length, Receptor, Insulin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
